Aspirin for the primary prevention of skin cancer: A meta-analysis

por ZHU, YUN, CHENG, YANG, LUO, RONG-CHENG, LI, AI-MIN
Publicado 2015

Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer

por Luo, Hai-Tao, Liang, Cai-Xia, Luo, Rong-Cheng, Gu, Wei-Guang
Publicado 2017

Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19

por Shen, Wei-Xi, Luo, Rong-Cheng, Wang, Jing-Quan, Chen, Zhe-Sheng
Publicado 2021

Autocrine, Not Paracrine, Interferon-Gamma Gene Delivery Enhances Ex Vivo Antigen-Specific Cytotoxic T Lymphocyte Stimulation and Killing

por Zhang, Dazhi, Liu, Yong, Shi, Min, You, Chang Xuan, Cao, Maohua, Luo, Rong Cheng, Hermonat, Paul L.
Publicado 2010

Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients

por Li, Shao-ying, Li, Rong, Chen, Yu-li, Xiong, Li-kuang, Wang, Hui-lin, Rong, Lei, Luo, Rong-cheng
Publicado 2014

TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling

por Liu, Fang, Cao, Qing-Hua, Lu, De-Jian, Luo, Bin, Lu, Xiao-Fang, Luo, Rong-Cheng, Wang, Xiao-Guang
Publicado 2015

Protein kinase D2 contributes to TNF-α-induced epithelial mesenchymal transition and invasion via the PI3K/GSK-3β/β-catenin pathway in hepatocellular carcinoma

por Zhu, Yun, Cheng, Yang, Guo, YaBin, Chen, JinZhang, Chen, FengSheng, Luo, RongCheng, Li, AiMin
Publicado 2015

Clinicopathological characteristics of patients with HER2-positive breast cancer and the efficacy of trastuzumab in the People’s Republic of China

por Zhou, Ping, Jiang, Yi-Zhou, Hu, Xin, Sun, Wei, Liu, Yi-Rong, Liu, Fang, Luo, Rong-Cheng, Shao, Zhi-Ming
Publicado 2016

A low serum Tat-interacting protein 30 level is a diagnostic and prognostic biomarker for hepatocellular carcinoma

por Fan, Sha-Sha, Liao, Chu-Shu, Cao, You-De, Xiao, Pei-Ling, Deng, Tan, Luo, Rong-Cheng, Duan, Hua-Xin
Publicado 2017

Differences in breast cancer characteristics and outcomes between Caucasian and Chinese women in the US

por Chen, Dan-Na, Song, Chuan-Gui, Ouyang, Qian-Wen, Jiang, Yi-Zhou, Ye, Fu-Gui, Ma, Fang-Jing, Luo, Rong-Cheng, Shao, Zhi-Ming
Publicado 2015

Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma

por Cheng, Yang, Luo, RongCheng, Zheng, Hang, Wang, Biao, Liu, YaHui, Liu, DingLi, Chen, JinZhang, Xu, WanFu, Li, AiMin, Zhu, Yun
Publicado 2017

Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma

por Lin, Xian, Li, Ai-min, Li, Yong-Hao, Luo, Rong-Cheng, Zou, Yu-Jiao, Liu, Yi-Yi, Liu, Chen, Xie, Ying-Ying, Zuo, Shi, Liu, Zhan, Liu, Zhen, Fang, Wei-Yi
Publicado 2020

Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients

por Xu, Bing-He, Jiang, Ze-Fei, Chua, Daniel, Shao, Zhi-Min, Luo, Rong-Cheng, Wang, Xiao-Jia, Liu, Dong-Geng, Yeo, Winnie, Yu, Shi-Ying, Newstat, Beth, Preston, Alka, Martin, Anne-Marie, Chi, Hai-Dong, Wang, Li
Publicado 2011

Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial

por Guan, Zhong-Zhen, Xu, Jian-Ming, Luo, Rong-Cheng, Feng, Feng-Yi, Wang, Li-Wei, Shen, Lin, Yu, Shi-Ying, Ba, Yi, Liang, Jun, Wang, Dong, Qin, Shu-Kui, Wang, Jie-Jun, He, Jing, Qi, Chuan, Xu, Rui-Hua
Publicado 2011

Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway

por Fu, Qiao-Fen, Liu, Yan, Fan, Yue, Hua, Sheng-Ni, Qu, Hong-Ying, Dong, Su-Wei, Li, Rui-Lei, Zhao, Meng-Yang, Zhen, Yan, Yu, Xiao-Li, Chen, Yi-Yu, Luo, Rong-Cheng, Li, Rong, Li, Li-Bo, Deng, Xiao-Jie, Fang, Wei-Yi, Liu, Zhen, Song, Xin
Publicado 2015

Recognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognition

por Rong, Xiao-Xiang, Wei, Fang, Lin, Xiao-Lin, Qin, Yu-Juan, Chen, Lin, Wang, Hui-Yan, Shen, Hong-Fen, Jia, Li-Ting, Xie, Rao-Ying, Lin, Tao-Yan, Hao, Wei-Chao, Yang, Jie, Yang, Sheng, Cheng, Yu-Shuang, Huang, Wen-Hua, Li, Ai-min, Sun, Yan, Luo, Rong-Cheng, Xiao, Dong
Publicado 2015

CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin’s Lymphoma

por Xue, YuanBo, Lai, Xun, Li, RuiLei, Ge, ChunLei, Zeng, BaoZhen, Li, Zhen, Fu, QiaoFen, Zhao, LiuFang, Dong, SuWei, Yang, JinYan, Guo, JiYin, Meng, QingYin, Tan, QingHua, Li, ZhenHui, Ding, HaiYan, Zhang, YanLei, Liu, ShaoHui, Chang, Alex H., Yao, Hong, Luo, RongCheng
Publicado 2021